We’ve assembled the most frequently asked questions about Eversense into one place. Got a question that you can’t find the answer to? Contact us.
It is safe for you to wear your sensor and smart transmitter when you go through metal detectors at airports. While flying, the smart transmitter performs similar to any other Bluetooth® device. Be sure to follow the specific safety guidelines mandated by the airline.
The Eversense® E3 Sensor can be used for up to 180 days before removal.
The most recent 90 days of your glucose data is stored in the app. Uninstalling/re-installing the app will clear all the data from the mobile device and only the most recent three days’ worth of glucose data will be retrieved from the smart transmitter and stored in the app.
Disposable adhesive patches for daily use are included as part of the system and will be provided to you by your health care professional after your sensor has been inserted. The patch has an acrylic adhesive side that attaches to the back of the smart transmitter, and a silicone adhesive side that attaches to the skin.
If you have insurance, your out of pocket cost will vary depending on your coverage and plan. If interested & qualified, we'd run a benefit investigation with your insurance company to confirm the cost.
If you're on commercial insurance, we have the PASS program that means you could pay as low as $199 for a full year. This includes the cost of both CGM sensor and transmitter.*
If you don't have insurance, call us at (945) 221-9068 to discuss cash-pay options.
The following steps outline how to pair your mobile device and smart transmitter.
NOTE: The smart transmitter should not be charging during the pairing process.
Still have questions?
The Eversense team is dedicated and ready to provide the answers and support you need. Simply click the link below.
The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
The Eversense® 365 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to one year in people (18 years and older) with diabetes. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are required for calibration one time a week after day 13, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense 365 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For important safety information, see bit.ly/eversensesafety
Eversense, Eversense E3 Continuous Glucose Monitoring, Eversense 365 Continuous Glucose Monitoring, and the Eversense logo are trademarks of Senseonics, Incorporated. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.
Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.
MKT-001692 Rev 1